IPO
Miragen Therapeutics, Inc.
They are a clinical-stage biopharmaceutical company discovering and developing proprietary RNA-targeted therapeutics with a specific focus on microRNAs and their roles in diseases where there is a high unmet medical need.
Symbol
MGEN
Price Range
$8.60 - $6.52
Effective Date
February 9, 2018
Underwriters
Jefferies, Evercore ISI, Deutsche Bank
To view the prospectus for Miragen Therapeutics, Inc. IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277